ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
Fruitbat2
|
185 |
46K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
46K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
Fruitbat2
|
185 |
46K |
6 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
185
|
46K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Fruitbat2
|
574 |
197K |
10 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
574
|
197K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Fruitbat2
|
574 |
197K |
6 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
574
|
197K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Dose escalates In Phase I Clinical Trial of New Oncolytic Vi
|
|
Fruitbat2
|
61 |
23K |
6 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
61
|
23K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
|
|
Fruitbat2
|
327 |
153K |
20 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
327
|
153K
|
20
|
|
ASX - By Stock
|
IMU |
M&A news
|
|
Fruitbat2
|
0 |
759 |
12 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
0
|
759
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
Fruitbat2
|
179 |
48K |
4 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
179
|
48K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
Fruitbat2
|
179 |
48K |
7 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
179
|
48K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $90 M placement and launches $5 M SPP
|
|
Fruitbat2
|
477 |
219K |
12 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
477
|
219K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $90 M placement and launches $5 M SPP
|
|
Fruitbat2
|
477 |
219K |
16 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
477
|
219K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $90 M placement and launches $5 M SPP
|
|
Fruitbat2
|
477 |
219K |
26 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
477
|
219K
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Fruitbat2
|
414 |
202K |
20 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
414
|
202K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Fruitbat2
|
17K |
6.7M |
4 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Fruitbat2
|
272 |
138K |
8 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Fruitbat2
|
10K |
3.0M |
18 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
Fruitbat2
|
175 |
41K |
1 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
175
|
41K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
Fruitbat2
|
175 |
41K |
4 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
175
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
Fruitbat2
|
175 |
41K |
4 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
175
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
Fruitbat2
|
175 |
41K |
20 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
175
|
41K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat
|
|
Fruitbat2
|
230 |
58K |
6 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
230
|
58K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Fruitbat2
|
1.0K |
517K |
3 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Fruitbat2
|
1.0K |
517K |
7 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Fruitbat2
|
1.0K |
517K |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Fruitbat2
|
17K |
6.7M |
18 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
17K
|
6.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Fruitbat2
|
443 |
199K |
7 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
443
|
199K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Fruitbat2
|
23K |
13M |
10 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB |
FDA Guidance on Regen Med
|
|
Fruitbat2
|
5 |
2.8K |
11 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
5
|
2.8K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Fruitbat2
|
4.4K |
2.4M |
17 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Fruitbat2
|
3.4K |
1.3M |
4 |
23/04/18 |
23/04/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
4
|
|
ASX - By Stock
|
MSB |
Chinese investment in Pluristem
|
|
Fruitbat2
|
0 |
709 |
1 |
26/10/16 |
26/10/16 |
ASX - By Stock
|
0
|
709
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Celgene
|
|
Fruitbat2
|
46 |
11K |
4 |
05/10/16 |
05/10/16 |
ASX - By Stock
|
46
|
11K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Celgene
|
|
Fruitbat2
|
46 |
11K |
6 |
05/10/16 |
05/10/16 |
ASX - By Stock
|
46
|
11K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
whats up here
|
|
Fruitbat2
|
65 |
17K |
2 |
22/09/16 |
22/09/16 |
ASX - By Stock
|
65
|
17K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
whats up here
|
|
Fruitbat2
|
65 |
17K |
1 |
22/09/16 |
22/09/16 |
ASX - By Stock
|
65
|
17K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
7 |
16/09/16 |
16/09/16 |
ASX - By Stock
|
141
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
6 |
16/09/16 |
16/09/16 |
ASX - By Stock
|
141
|
31K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
3 |
16/09/16 |
16/09/16 |
ASX - By Stock
|
141
|
31K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
7 |
15/09/16 |
15/09/16 |
ASX - By Stock
|
141
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
7 |
15/09/16 |
15/09/16 |
ASX - By Stock
|
141
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
S C Market expected CAGR 25.5% Growth
|
|
Fruitbat2
|
141 |
31K |
7 |
14/09/16 |
14/09/16 |
ASX - By Stock
|
141
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Clinical data
|
|
Fruitbat2
|
2 |
1.1K |
3 |
31/08/16 |
31/08/16 |
ASX - By Stock
|
2
|
1.1K
|
3
|
|
ASX - By Stock
|
MSB |
Cardiac stem cell study
|
|
Fruitbat2
|
5 |
1.8K |
6 |
25/07/16 |
25/07/16 |
ASX - By Stock
|
5
|
1.8K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
TEVA as equity financer????
|
|
Fruitbat2
|
214 |
40K |
5 |
16/06/16 |
16/06/16 |
ASX - By Stock
|
214
|
40K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
TEVA as equity financer????
|
|
Fruitbat2
|
214 |
40K |
2 |
16/06/16 |
16/06/16 |
ASX - By Stock
|
214
|
40K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
TEVA as equity financer????
|
|
Fruitbat2
|
214 |
40K |
6 |
16/06/16 |
16/06/16 |
ASX - By Stock
|
214
|
40K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Global Heart Failure Program-MSB.AX
|
|
Fruitbat2
|
174 |
50K |
7 |
14/06/16 |
14/06/16 |
ASX - By Stock
|
174
|
50K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Global Heart Failure Program-MSB.AX
|
|
Fruitbat2
|
174 |
50K |
16 |
14/06/16 |
14/06/16 |
ASX - By Stock
|
174
|
50K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
If MSB were a mining company...
|
|
Fruitbat2
|
75 |
18K |
0 |
13/05/16 |
13/05/16 |
ASX - By Stock
|
75
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
If MSB were a mining company...
|
|
Fruitbat2
|
75 |
18K |
1 |
13/05/16 |
13/05/16 |
ASX - By Stock
|
75
|
18K
|
1
|
|